ClinicalTrials.gg
CompletedNCT02437929Updated Jul 12, 2016

Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment

An observational study in Breakthrough Pain, Pain Due to Certain Specified Procedures and Pain, sponsored by Antea Foundation. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-07-12.

Sponsored by Antea Foundation · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
1,079
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to assess self reported procedural pain compared with background pain and evaluate pain intensity differences across six standard procedures. Besides, rescue and preventive treatments used to control procedural pain will be examined.

02

Conditions studied

  • Breakthrough Pain
  • Pain Due to Certain Specified Procedures
  • Pain
  • Cancer
  • Terminal Disease
03

In context

Breakthrough Pain

34 studies on the registry are indexed under Breakthrough Pain; 4 are open to participants now.

This study's enrollment of 1,079 is above the median of 125 across 10 observational studies indexed under Breakthrough Pain.

Browse Breakthrough Pain studies →

Lead sponsor

Antea Foundation is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Terminally ill patients, cancer and non-cancer, admitted in a palliative care service (inpatients or outpatients), that are undergoing at least one procedure considered in the study, as a part of their Individual Care Plan (ICP).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients receiving the procedures included in this study as a part of their standard care
  • Patients that have expressed their consent to participate to the study by signing the document

Exclusion criteria

Exclusion Criteria:

  • Very serious or unstable clinical conditions with a Performance Status Index (KPS) \< 20
  • Presence of neurological or psychiatric conditions, due to the original disease or concomitant diseases, interfering with the patient's level of consciousness or with judgment, such as to compromise compliance with the study protocol;
  • Not adequately controlled background pain (average NRS in the last 24 hours is > 4)
  • Emergency procedures or procedures performed during night time (from 8 p.m. until 8 a.m)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Karnofsky performance status (KPS)

A 0–100 scale of how well someone can carry out everyday activities. 100 is no complaints and no signs of illness; 70 is able to look after yourself but not to work or keep up normal activity; 50 is needing considerable help and frequent medical care.

Studies often ask for 60 or 70 and above. Your doctor gives the score.

05

Study design

Time perspective
Prospective
Enrollment
1,079 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients receiving standard procedures

    Procedure: Mobilization · Procedure: Positioning · Procedure: Personal Hygiene Care · Procedure: Bladder catheterization · Procedure: Wound care · Procedure: Subcutaneous drugs administration

Interventions

  • ProcedureMobilization
  • ProcedurePositioning
  • ProcedurePersonal Hygiene Care
  • ProcedureBladder catheterization
  • ProcedureWound care
  • ProcedureSubcutaneous drugs administration
06

What researchers measure

Primary outcomes

  1. 11 Points - Numerical Rating Scale (NRS); change in baseline pain intensity during the procedure (of 3 points NRS or higher)

    Self reported pain intensity 10 minutes before the procedure, during the procedure (measured immediately after that the procedure is performed), 10 minutes after the procedure. Each item is scored 0-10 (0 = no pain; 10 = worst possible pain).

    Time frame: Participants will be followed 10 minutes before the procedure, for the duration of the procedure and ten minutes after, an expected average of 1 hour

07

Study locations

1 site
  • San Marco hospice
    Latina, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2015, a primary completion of Dec 2015 and a completion of Apr 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2015
First posted
May 8, 2015
Start
Jun 2015
Primary completionActual
Dec 2015
CompletionActual
Apr 2016
Last update
Jul 12, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 12, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02437929
Lead sponsor
Antea Foundation
Responsible party
Sponsor
First posted
May 8, 2015
Start date
Jun 2015
Primary completion
Dec 2015
Completion
Apr 2016
Last update
Jul 12, 2016

Study contacts

Giuseppe Casale, Medicine
principal investigator · Antea Foundation

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion